A team of researchers from the Kobe University Graduate School of Medicine in Japan have developed a metabolomics-based approach to diagnose early-stage pancreatic cancer.1 The method uses gas chromatography coupled to mass spectrometry (GC?MS).
A team of researchers from the Kobe University Graduate School of Medicine in Japan have developed a metabolomics-based approach to diagnose early-stage pancreatic cancer.1 The method uses gas chromatography coupled to mass spectrometry (GC–MS).
Corresponding author Dr Masaru Yoshida commented: “Although surgical resection can be a curative treatment for pancreatic cancer, more than 80% of patients with pancreatic cancer have a locally advanced or metastatic tumour that is unresectable at the time of detection.” This is why scientists globally are trying to develop new methodsto detect the cancer in the earlier stages.
The team collected serum samples from 43 patients diagnosed with pancreatic cancer and 42 healthy volunteers. The analysis of the samples was challenging for the investigators. According to Yoshida, it was tough to measure several hundred metabolites in the serum samples at the same time with GC–MS.
The serum samples were compared from the two patient groups — in total, 159 metabolites were detected with 18 found to be significantly altered. The team developed and optimized the GC–MS method and selected four metabolites of interest to establish a diagnostic formula.
According to Yoshida, the novel diagnostic approach is safe and easy to apply. He told The Column that it is “expected to improve prognosis of patients diagnosed with pancreatic cancer by detecting their cancer early, when still in a resectable and curable state.”
Reference
1. T. Kobayashi et al, Cancer, Epidemiology, Biomarkers & Prevention,DOI:10.1158/1055-9965 (2013).
This story originally appeared in The Column. Click here to view that issue.
Inside the Laboratory: The Gionfriddo Group at the University at Buffalo
March 28th 2024In this edition of “Inside the Laboratory,” Emanuela Gionfriddo, PhD, an associate professor of chemistry at the University at Buffalo, discusses her group’s current research endeavors, including using solid-phase microextraction (SPME) coupled to liquid chromatography (LC) and gas chromatography (GC) to further understand the chemical relationship between environmental exposure and disease and elucidate micropollutants fate in the environment and biological systems.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.